Bellerophon Therapeutics Inc (NASDAQ:BLPH)
| 3.82 Delayed Data As of Oct 26 |  -0.04 / -1.04%Today’s Change | 3.66 Today|||52-Week Range 9.75 | -42.73% Year-to-Date |
Latest BLPH News | Press Releases
No recent news for Bellerophon Therapeutics Inc.
Today’s Trading
| Previous close | 3.84 |
| Today’s open | 3.93 |
| Day’s range | 3.71 - 3.93 |
| Volume | 65,842 |
| Average volume (3 months) | 133,557 |
| Market cap | $36.6M |
Data as of 3:59pm ET, 10/26/2021
Growth & Valuation
| Earnings growth (last year) | -7.65% |
| Earnings growth (this year) | +29.97% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.95 |
Competitors
Data as of 4:00pm ET, 10/26/2021
Financials
| Next reporting date | November 9, 2021 |
| EPS forecast (this quarter) | -$0.63 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$24.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Warren, New Jersey |
Forecasts
